The Aperlena Verdict
Open raceNo supplier dominates: 235 different companies have won the last 592 comparable contracts from this buyer over 5 years. This is a genuinely open race.
- 0%
- Expected final price vs the published estimate
Based on 592 comparable awards by this buyer in this sector over 5 years. Every verdict is recorded before the outcome and graded against the award notice. How we score ourselves.
Summary
Machine-generated summaryThis tender covers the supply of reagents for the anatomical pathology service for the year 2023. The contracting authority is purchasing laboratory reagents and related consumables used in anatomical pathology diagnostics, supporting the routine testing and analysis carried out by the pathology department. The supply relates to the 2023 annual requirements of the service, and the products must be suitable for use in the laboratory procedures of the anatomical pathology unit. The notice does not provide a detailed description beyond the title, so bidders should consult the full tender documents for specifications, quantities and delivery arrangements.
Official source
Source: BASE - Portal dos Contratos Públicos (IMPIC)
Always verify details on the official notice.
Last verified against BASE - Portal dos Contratos Públicos (IMPIC) 1 day ago
The official portal may ask for a free registration before downloading.
More from this buyer
Full buyer profile127 open tenders right now
- 261A000115 - Reagents 1 day left
- 269A000059 - Acquisition of Support Products for the Physical Medicine and Rehabilitation Service (MFR), for the provision of Technical Aids to patients in 2026 1 day left
- Acquisition of maintenance services for the hyperconverged solution for the year 2026 6 days left
Who usually wins this buyer's contracts in this sector
| Company | Wins | Total awarded | Last win |
|---|---|---|---|
| GENERIS FARMACÊUTICA S.A | 17 | €146,661 | Sep 2026 |
| ACCORD HEALTHCARE UNIPESSOAL LDA | 16 | €363,988 | Aug 2026 |
| XPHARMA, Lda. | 14 | €51,218 | Sep 2026 |
| GENERIS - FARMACEUTICA, S.A. | 13 | €346,779 | Aug 2026 |
| Cencora 3PL Portugal, S.A. | 12 | €621,703 | Aug 2026 |
Based on 592 awards with a linked company profile over the last 5 years.
What this buyer has paid before
Based on 597 comparable contracts this buyer awarded in this sector over the last 4 years.
- €1,495
- Lower quartile
- €6,979
- Median award
- €27,490
- Upper quartile
This tender is estimated 1041.7% above that median
Most recent awards
- 261Y000564 - AQUISIÇÃO DE IMPREGNADO COM MEL 40% EM SUPORTE SINTÉTICO 10 x 10 CM PARA O ANO DE 2026 €3,450
- 261G000983/13559 - VÁRIOS REAGENTES €810
- 261G0001029 - citrato de CAFEINA 10 MG/ 1ML INJ ORAL/ IV €9,000
- 261X000240 - AQUISIÇÃO DE IMUNOGLOBULINA RICA EM IgA E IgM 50 MG/ML SOL INJ FR 100 ML (5%) (PENTAGLOBIN) €59,707
- 261G001020/35361 - Serviço Patologia Clinica -Core Lab HSM €5,129
Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.
Similar tenders
1
day left
€492,900
est. value
1
day left
€114,600
est. value
1
day left
€450,174
est. value
1
day left
€229,581
est. value
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €9,890,377
- Buyer track record on Aperlena
- 2,716 notices tracked · 918 awarded
- €36,127,947 in awarded contracts
Never miss a tender like this
18,563 new notices in Medical equipment & pharmaceuticals in Portugal in the last 7 days. Get an email when new ones appear. Free.
Set up my alert